Skip to main content
Premium Trial:

Request an Annual Quote

"Other Interests"

Billy Tauzin, president of the Pharmaceutical Research and Manufacturers of America, has resigned, effective in June, reports the Wall Street Journal. The Journal points out that Tauzin had been "taking criticism for his support of the White House's now-teetering plan to overhaul health care." Though Tauzin's departure is so that he can pursue "other interests," NPR's Shots blog notes that "it appears he may also be on the outs with some of the companies he represents in Washington" due to Tauzin's deals with Democrats on healthcare reform. Prior to joining PhRMA in January 2005, Tauzin represented Louisiana and chaired the House committee that oversaw healthcare.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.